Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 540k | $6.9k | 0% | Jun 2026 |
|
| Morgan Stanley | 146k | $3.7k | 0% | Mar 2026 |
|
| Clear Street Group | 79k | $1.0k | 0% | Jun 2026 |
|
| Millennium Management | 63k | $800.000000 | 0% | Jun 2026 |
|
| Gts Securities | 41k | $536.913000 | 1% | Jun 2026 |
|
| Virtu Financial | 21k | $0 | 100% | Jun 2026 |
|
| UBS Group | 6.6k | $84.714300 | 57% | Jun 2026 |
|
| Wolverine Asset Management | 3.3k | $42.099200 | 82% | Jun 2026 |
|
| Toronto-Dominion Bank | 300.00 | $3.990000 | 100% | Jun 2026 |
|